D. E. Shaw & Co. Inc. Has $1.09 Million Position in Core Laboratories Inc. (NYSE:CLB)

D. E. Shaw & Co. Inc. reduced its stake in Core Laboratories Inc. (NYSE:CLB - Free Report) by 54.7% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 63,082 shares of the oil and gas company's stock after selling 76,098 shares during the period. D. E. Shaw & Co. Inc. owned 0.13% of Core Laboratories worth $1,092,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Assetmark Inc. acquired a new position in Core Laboratories in the fourth quarter valued at about $26,000. Smartleaf Asset Management LLC raised its position in shares of Core Laboratories by 173.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 2,037 shares of the oil and gas company's stock valued at $35,000 after acquiring an additional 1,293 shares during the period. Nisa Investment Advisors LLC raised its position in shares of Core Laboratories by 2,688.5% in the 4th quarter. Nisa Investment Advisors LLC now owns 2,426 shares of the oil and gas company's stock valued at $42,000 after acquiring an additional 2,339 shares during the period. Tower Research Capital LLC TRC boosted its stake in Core Laboratories by 843.7% during the 4th quarter. Tower Research Capital LLC TRC now owns 3,284 shares of the oil and gas company's stock worth $57,000 after acquiring an additional 2,936 shares during the last quarter. Finally, BNP Paribas Financial Markets bought a new position in shares of Core Laboratories during the fourth quarter worth $123,000. 97.81% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently commented on the stock. Wall Street Zen cut shares of Core Laboratories from a "hold" rating to a "sell" rating in a research report on Friday, April 25th. Citigroup lowered their price target on Core Laboratories from $16.00 to $13.00 and set a "neutral" rating for the company in a report on Tuesday, May 13th. Finally, Stifel Nicolaus dropped their price target on Core Laboratories from $19.00 to $15.00 and set a "hold" rating on the stock in a research report on Tuesday, April 15th. Two analysts have rated the stock with a sell rating and three have given a hold rating to the company's stock. According to MarketBeat, the company has an average rating of "Hold" and a consensus price target of $15.00.

Core Laboratories Stock Up 2.1%

NYSE CLB traded up $0.22 on Thursday, reaching $11.03. The company had a trading volume of 222,252 shares, compared to its average volume of 405,342. The company's fifty day moving average is $12.27 and its 200-day moving average is $15.92. The firm has a market capitalization of $517.21 million, a price-to-earnings ratio of 16.72, a price-to-earnings-growth ratio of 0.99 and a beta of 1.45. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.71 and a current ratio of 2.32. Core Laboratories Inc. has a 1-year low of $10.14 and a 1-year high of $25.13.

Core Laboratories (NYSE:CLB - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The oil and gas company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.01). Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%. The firm had revenue of $123.59 million for the quarter, compared to analyst estimates of $125.09 million. During the same period in the prior year, the company earned $0.19 earnings per share. The firm's quarterly revenue was down 4.7% on a year-over-year basis. On average, research analysts forecast that Core Laboratories Inc. will post 0.96 earnings per share for the current fiscal year.

Core Laboratories Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, May 27th. Stockholders of record on Monday, May 5th were given a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.36%. The ex-dividend date was Monday, May 5th. Core Laboratories's dividend payout ratio is presently 6.78%.

Core Laboratories Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.